photo by Michael Miller

Life Sciences Executive, Jamie Coffin, Ph.D, Appointed to Terascala Board of Directors

Coffin, former worldwide vice president and general manager of Dell’s Healthcare Life Science organization, says Terascala provides critical component in next generation, HPC infrastructure for whole genome analysis.

Boston, MA -- April 29, 2014 --Today Terascala announced that Jamie Coffin, former worldwide vice president and general manager for Dell Healthcare and Life Science division, has joined Terascala’s Board of Directors. Terascala’s unique software and hardware solutions combined with Dell hardware substantially accelerate whole genome analysis while lowering the cost of the HPC infrastructure required.

The appointment of Coffin is a direct result of Terascala’s momentum in life sciences, specifically in the genome analysis industry. Coffin’s background as a computational chemist, followed by executive leadership positions in life sciences at IBM and Dell, provide him with a unique perspective in this industry.

According to Coffin, the life sciences industry, especially next generation sequencing (NGS), is embracing HPC at an increasingly fast pace. “While the ability to sequence genetic data has made dramatic leaps over the past several years, the ability to collect, store, and analyze that data is a growing challenge. For many organizations, NGS is an exciting possibility, yet it is still beyond the reach of their budgets and capabilities. With Terascala, that’s no longer the case.”

Terascala allows organizations to combine larger compute clusters and turnkey, multi-tier storage with a high performance data mover to manage the data across the infrastructure. Coffin sees great potential in helping to drive that vision into the life sciences community.

“Terascala’s TeraOS and Intelligent Storage Bridge high-performance data movement solution have made the two tier storage architecture a reality, delivering real advantages in cost, flexibility, and performance over monolithic storage approaches common in today’s sequencing organizations. Further, Terascala’s technology makes it incredibly easy for organizations of all sizes to deploy HPC because it enables fast, simple, and easy to use appliances. That’s the recipe the life sciences industry has always desired, and I am excited to be a part of it,” concluded Coffin.

Terascala believes that Coffin’s tremendous insight into the life science markets will help further the company’s momentum in the industry. “We are pleased to welcome someone with Jamie’s experience and reputation to the Terascala board,” commented Steve Butler, Terascala’s CEO. “Jamie has seen how Terascala is becoming a critical component in next generation sequencing. We are confident that his knowledge, expertise and relationships will help us accelerate our success in this rapidly growing industry.”

From January 2007 through April 2013, Coffin was general manager for Dell’s Global Heathcare Life Science (HCLS) business. Over the six year period, he grew the organization to 13,000 employees worldwide, tripled revenue and significantly increased margins. Coffin transformed this business into the top healthcare information technology services company in the world. Prior to Dell, Coffin was worldwide vice president of IBM Healthcare and Life Sciences. His core activities at IBM included leading a $5 billion server, software, and service business with global leadership of 800+ sales, new business development, and technical support professionals.